Hemarus Therapeutics Limited

Hemarus Therapeutics Limited - life sciences in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U74220TG2003PLC041698 Incorporated 16 September 2003 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Public Limited Company life sciences
Revenue · FY 2025
₹900
▼ 84.64% YoY
Authorised capital
₹40 Cr
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Satisfied charges
₹75.4 Cr
No open charges
Company age
23 yrs
Est. 2003
Employees · EPFO
67
Provident fund records
Directors on board
3
As per MCA filings
GST registrations
2
None active

About Hemarus Therapeutics Limited

Data last updated:

Hemarus Therapeutics Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 16 September 2003 and has been in existence for over 23 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74220TG2003PLC041698. The company has 2 GST registrations on record, none of which is active.

The company has an authorised share capital of ₹40 Cr and a paid-up capital of ₹10 Lakh. It was formerly known as Hemarus Therapeutics Private Limited and Credence Clinical Research Private Limited. It is led by directors including Kavali Dharmendra and Balaraju Jittaboina.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.

The company has about 67 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Hemarus. As per MCA filings, the company has satisfied charges of ₹75.4 Cr on record. Court records list 14 cases involving the company, including 9 filed by the company and 5 filed against it; 3 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hemarus.co.in.

Company details

CIN U74220TG2003PLC041698
Registration Number 041698
Incorporation Date 16 September 2003
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Name history

Hemarus Therapeutics has undergone 2 name changes throughout its history. The company was previously known as Hemarus Therapeutics Private Limited, and Credence Clinical Research Private Limited. The current legal name is Hemarus Therapeutics Limited.

Company NameStatus
Hemarus Therapeutics LimitedCurrent
Hemarus Therapeutics Private LimitedPrevious
Credence Clinical Research Private LimitedPrevious

CIN history

Hemarus Therapeutics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U74220TG2003PLC041698, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74220TG2003PLC041698Current
U74220AP2003PTC041698Previous
U74220AP2003PLC041698Previous

Contact details

Hemarus Therapeutics Limited's registered office is in Hyderabad, Telangana. Its website is hemarus.co.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    8 – 2 – 293/82/Jiii/359, Plot No.359 – III Raod No.80 Jubilee Hills, Hyderabad, Telangana, India – 500033
  • Industry
    Life Sciences, Biotechnology

To see the full contact details of Hemarus Therapeutics Limited, buy the company report.

Comprehensive company report
Hemarus Therapeutics Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Hemarus Therapeutics operates one associated brand: Hemarus. Each brand links to its own profile.

BrandDescriptionWebsite
Specialty plasma derived biopharmaceuticals for bleeding disordershemarus.co.in

Business activity

The main business activity of Hemarus Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

Financials of Hemarus Therapeutics Limited

FY 2025 filings available

Hemarus Therapeutics Limited reported revenue of ₹900 for FY 2025.

Revenue · FY 2025
₹900

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▼ 98%
5 years · compounded
▼ 93%

Revenue has declined at a compounded annual rate (CAGR) of 93% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Hemarus Therapeutics Limited, buy the company report.

Board of directors of Hemarus Therapeutics Limited

Hemarus Therapeutics has 3 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kavali DharmendraDirector25 Oct 20242 Years 0 MonthsCurrent
Balaraju JittaboinaDirector25 Oct 20242 Years 0 MonthsCurrent
Santosh Kumar SuranaDirector25 Oct 20242 Years 0 MonthsCurrent

Auditor

Hemarus Therapeutics Limited is audited by Ganeshvenkat & Co for the financial year 2022.

Auditor firmFinancial yearFirm registration number
Ganeshvenkat & CoFY 2022005293S

Shareholding

The shareholding of Hemarus Therapeutics Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Hemarus Therapeutics Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹75.4 Cr
Breakdown by lending institutions
Indian Overseas Bank₹66.68 Cr
Andhra Pradesh State Financial Corporation₹8.72 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Feb 201110280683Indian Overseas Bank₹66.68 CrSatisfied
10 Aug 200490131380Andhra Pradesh State Financial Corporation₹8.72 CrSatisfied

To see the full charge records of Hemarus Therapeutics Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Hemarus Therapeutics Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Hemarus Therapeutics Limited has a workforce of 67 employees on its EPFO records as of May 2021, across 1 active EPFO establishment.

Employee count
67
Active EPFO establishments
1
Employee growth
11.7%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2021-2267
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17
FY 2015-16
FY 2014-15

To see the full employee and EPFO history of Hemarus Therapeutics Limited, buy the company report.

GST

Hemarus Therapeutics has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.

Total GSTINs
2
Cancelled / inactive
2

To see the full GST registrations and return filing status of Hemarus Therapeutics Limited, buy the company report.

Recent activity

Hemarus Therapeutics Limited has 18 board changes on record since 2013: 3 appointments and 15 cessations. The latest: Ramana Reddy Malireddy ceased to be Irp/Rp/Liquidator on 21 Dec 2024.

AGM
Hemarus Therapeutics Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hemarus Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Ramana Reddy Malireddy ceased to be Irp/Rp/Liquidator.
Appointed
Balaraju Jittaboina was appointed as Director.
Appointed
Kavali Dharmendra was appointed as Director.
Appointed
Santosh Kumar Surana was appointed as Director.
Ceased
Talari Venkatesh ceased to be Director.
Ceased
Satish Narayan Saudam ceased to be Additional Director.
Ceased
Uma Devi Komath ceased to be Managing Director.
Ceased
Satish Ganne ceased to be Additional Director.
Ceased
Dipak Chattaraj ceased to be Director.
Ceased
Dr Denis Broun ceased to be Director.

15 earlier events are in the company report.

Frequently asked questions

Hemarus Therapeutics is an active public limited company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 16 September 2003 (23+ years old) and is registered under CIN U74220TG2003PLC041698.

Hemarus Therapeutics has 3 current directors:

The latest financial statements of Hemarus Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

No. Hemarus Therapeutics has 2 GST registrations on record and all of them are cancelled or inactive.

The CIN (Corporate Identification Number) of Hemarus Therapeutics is U74220TG2003PLC041698. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Hemarus Therapeutics has 14 court cases on record: 9 filed by the company and 5 filed against it. 3 are pending. Most are in the high courts.

Hemarus Therapeutics was incorporated on 16 September 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.

Ramana Reddy Malireddy ceased to be Irp/Rp/Liquidator on 21 Dec 2024. Balaraju Jittaboina was appointed as Director on 25 Oct 2024. Kavali Dharmendra was appointed as Director on 25 Oct 2024. Hemarus Therapeutics has 18 board changes on record in total.

Hemarus Therapeutics can be reached through the website hemarus.co.in. Its registered office is in Hyderabad, Telangana, India.

The registered office of Hemarus Therapeutics is at 8 – 2 – 29382Jiii359, Plot No.359 – III Raod No.80 Jubilee Hills, Hyderabad, Telangana, India – 500033.